MetaSano

Published by: Guizo Studios

Description

MetaSano is a "food-as-medicine" platform for stage 3 chronic kidney disease. Patients log their meals, and our system compares them to dietary guidelines or personalized nutritionist recommendations. The platform also helps nutritionists monitor patients’ progress and provides CKD-specific guidance, supporting users in following their diet to slow disease progression.

While MetaSano provides valuable insights and guidance, it is important to remember that it is not a substitute for professional medical advice. Always consult with a qualified healthcare provider before making any significant changes to your health regimen, taking any medication, or if you have any concerns about your health. MetaSano is intended to complement, not replace, the relationship between you and your healthcare provider.

Terms of Use: https://www.apple.com/legal/internet-services/itunes/dev/stdeula/
Hide Show More...

Screenshots

MetaSano FAQ

  • Is MetaSano free?

    Yes, MetaSano is completely free and it doesn't have any in-app purchases or subscriptions.

  • Is MetaSano legit?

    Not enough reviews to make a reliable assessment. The app needs more user feedback.

    Thanks for the vote

  • How much does MetaSano cost?

    MetaSano is free.

  • What is MetaSano revenue?

    To get estimated revenue of MetaSano app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.

User Rating
App is not rated in Spain yet.
Ratings History

MetaSano Reviews

No Reviews in Spain
App doesn't have any reviews in Spain yet.

Store Rankings

Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet

MetaSano Installs

Last 30 days

MetaSano Revenue

Last 30 days

MetaSano Revenue and Downloads

Gain valuable insights into MetaSano performance with our analytics.
Sign up now to access downloads, revenue, and more.

App Info

Publisher
Guizo Studios
Languages
English, French, Portuguese, Spanish
Recent release
1.1.16 (1 month ago )
Released on
Feb 6, 2024 (11 months ago )
Last Updated
4 days ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.